Back

The effect of amiodarone given periprocedurally on the effectiveness of catheter ablation in patients with persistent atrial fibrillation refractory to cardioversion

7 April 2024 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session on atrial fibrillation and supraventricular tachycardia Rhythm Control, Antiarrhythmic Drugs EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Grzegorz Ehrenhalt

National Institute of Cardiology, Warsaw (Poland)

116 More presentations in this session

Presentation thumbnail
Left atrial strain measurement in patients with heart failure and atrial fibrillation compared to a control group
Doctor L. Herzer (Jena, DE)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation after transcatheter tricuspid valve repair: rhythm control strategies and outcomes
Doctor J. Schipper (Cologne, DE)
Abstract
Presentation thumbnail
Left atrial strain defines functional and structural remodeling in patients with persistent atrial fibrillation
Doctor A. Grosse (Jena, DE)
Abstract Slides Video
Presentation thumbnail
Cryoballoon ablation for atrial fibrillation in young adults: a propensity-score matching comparison with an older cohort
Presentation thumbnail
Procedural safety and outcome of additional left atrial posterior wall ablation using pulse field ablation for atrial fibrillation
Doctor J. Tay Cheong Kiat (Singapore, SG)
Abstract Slides Video

Access the full session

Session thumbnail
Poster session on atrial fibrillation and supraventricular tachycardia

The Event

Event poster

EHRA 2024

7 April 2024 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Restoration, but not maintenance of sinus rhythm during amiodarone pretreatment predicts the success of pulmonary vein isolation in persistent atrial fibrillation
1 April 2025
thumbnail
Congress Presentation
General anaesthesia during radiofrequency ablation of atrial fibrillation is associated with improved procedural characteristics but with similar long-term outcomes: a single center study.
23 April 2021
thumbnail
Congress Presentation
Spatial distribution of effective refractory period in atrial fibrillation patients
12 April 2026
thumbnail
Congress Presentation
Long-term heart failure improvement after catheter ablation of persistent atrial fibrillation in heart failure with preserved, mildly reduced and reduced ejection fraction
30 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources